DIA Biosimilars 2013

Human Genome Sciences

HGS’s Benlysta grosses $59 million

Wednesday, January 11, 2012 11:05 AM

Benlysta (belimumab), the first approved drug for systemic lupus in 56 years, has already grossed $59.2 million, averaging $2.3 million in sales per week since it received FDA approval less than a year ago, according to Human Genome Sciences (HGS).

More... »

Cenduit: Now with Patient Reminders

Mirani joins DaVita Labs

Thursday, December 1, 2011 10:43 AM
DaVita Labs has named Leslie Mirani vice president and general manager. 

More... »

CRF Health – eCOA Forum

Parker joins Human Genome Sciences as VP

Monday, August 8, 2011 12:08 PM

Human Genome Sciences has named Craig C. Parker its senior vice president, strategy and corporate development. He will report directly to H. Thomas Watkins, president and chief executive officer, and will serve as a member of the management committee.

More... »

The CenterWatch Monthly, May 2011

Monday, May 2, 2011 11:05 AM

Sites worldwide rate PPD, Kendle, ICON top CROs

More... »

Anadys appoints Barry Labinger to board of directors

Friday, March 18, 2011 10:44 AM

Anadys Pharmaceuticals has appointed Barry A. Labinger to its board of directors. Labinger is executive vice president and chief commercial officer of Human Genome Sciences.

More... »

Human Genome partners with FivePrime

Thursday, March 17, 2011 12:25 PM

Human Genome Sciences said it will develop and commercialize a drug for multiple cancers from FivePrime Therapeutics in the U.S., Canada and European markets, according to a Reuters report.

More... »

Genetics remains at top of academic research

Friday, March 11, 2011 01:51 PM

Genetics is still the hottest area of scientific research, a decade since the mapping of the human genome, despite slow progress in translating discoveries into new medical treatments, according to a report in Reuters.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.